InvestSMART

ImpediMed Limited (ASX:IPD)

ALERT: Price-sensitive ASX Announcement for IPD
Current share price for IPD : $0.005 -0.009 (-64.29%)+
Announcement
Release
4 May 2026 10:55AM
Price at Release
$0.014
Full Release
download
Summary
ImpediMed Limited, an Australian medical technology company, announced a successful capital raise of $15.2 million AUD. The capital raise was conducted through a two-tranche institutional placement of $13.2 million and a share purchase plan (SPP) of up to $2 million. The proceeds will be used to partially prepay the SWK Growth Capital Facility and provide working capital to support ongoing operations and commercial strategies, especially in the US market. Additionally, the company plans to implement operational initiatives to achieve annualized cost reductions of $5 million AUD. The company received strong support from new and existing investors, including directors, and aims for operating cash flow breakeven by FY28 assuming full exercise of options. The capital raise is subject to shareholder approval scheduled for mid-June 2026.
Key Points
  • Successful capital raise of $15.2 million AUD
  • Two-tranche placement: $13.2 million, SPP: up to $2 million
  • Proceeds to reduce debt and support operations
  • Operational initiatives for $5 million AUD cost reductions
  • Strong investor support and director participation
  • Pathway to cash flow breakeven by FY28
  • Subject to shareholder approval in June 2026
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.